Protein Kinase CK2 and Its Potential Role as a Therapeutic Target in Huntington’s Disease

Huntington’s Disease (HD) is a devastating neurodegenerative disorder caused by a CAG trinucleotide repeat expansion in the HTT gene, for which no disease modifying therapies are currently available. Much of the recent research has focused on developing therapies to directly lower HTT expression, an...

Descripción completa

Detalles Bibliográficos
Autores principales: White, Angel, McGlone, Anna, Gomez-Pastor, Rocio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406209/
https://www.ncbi.nlm.nih.gov/pubmed/36009526
http://dx.doi.org/10.3390/biomedicines10081979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406209/
https://www.ncbi.nlm.nih.gov/pubmed/36009526
http://dx.doi.org/10.3390/biomedicines10081979

Ejemplares similares